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Abstract 
Background: Limonene, a monocyclic monoterpene, is known for its using as an important precursor of many 
flavoring, pharmaceutical, and biodiesel products. Currently, d‑limonene has been produced via fractionation from 
essential oils or as a byproduct of orange juice production, however, considering the increasing need for limonene 
and a certain amount of pesticides may exist in the limonene obtained from the citrus industry, some other methods 
should be explored to produce limonene.
Results: To construct the limonene synthetic pathway in Yarrowia lipolytica, two genes encoding neryl diphosphate 
synthase 1 (NDPS1) and limonene synthase (LS) were codon‑optimized and heterologously expressed in Y. lipolytica. 
Furthermore, to maximize limonene production, several genes involved in the MVA pathway were overexpressed, 
either in different copies of the same gene or in combination. Finally with the optimized pyruvic acid and dodecane 
concentration in flask culture, a maximum limonene titer and content of 23.56 mg/L and 1.36 mg/g DCW were 
achieved in the final engineered strain Po1f‑LN‑051, showing approximately 226‑fold increase compared with the 
initial yield 0.006 mg/g DCW.
Conclusions: This is the first report on limonene biosynthesis in oleaginous yeast Y. lipolytica by heterologous 
expression of codon‑optimized tLS and tNDPS1 genes. To our knowledge, the limonene production 23.56 mg/L, is the 
highest limonene production level reported in yeast. In short, we demonstrate that Y. lipolytica provides a compelling 
platform for the overproduction of limonene derivatives, and even other monoterpenes.
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Background
Natural compound monoterpenes are C10 compounds 
that consist of two isoprene units. Monoterpenes belong 
to a large family of plant secondary metabolites with val-
uable applications including using as biofuels, feedstocks 
for pharmaceutical and other industrial product syn-
theses, and flavors and fragrances [4, 13, 23]. Limonene, 
a monocyclic monoterpene, is famous for its citrus-like 
olfactory properties. Limonene is also an important pre-
cursor of many flavor and medicinal compounds such 
as perillyl alcohol (POH), carvone, and menthol [1, 13]. 
Limonene has three isomers: d-limonene, dl-limonene, 
and l-limonene. They all consist in natural plants, while 
d-limonene is the most widespread [32]. D-limonene 
is considered as GRAS (generally recognized as safe) 
material by the US Food and Drug Administration [19]. 
Furthermore, d-limonene is widely used as a flavoring 
or fragrance agent in pharmaceuticals, foods, and bev-
erages [27]. Currently, d-limonene has been produced 
via fractionation from essential oils or as a byproduct of 
orange juice production, but considering the increasing 
need for limonene as a polymer and as a jet fuel, the cit-
rus industry may not be able to meet future demands. In 
the meantime, a certain amount of pesticides may exist 
in the limonene obtained from the citrus industry, so it is 
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necessary that some other methods should be explored to 
produce limonene [10, 13].
Metabolic engineering of microorganisms to produce 
natural products seems to be a good choice. Many ter-
penoids have been produced by various kinds of micro-
organisms, such as lycopene produced in Yarrowia 
lipolytica; miltiradiene and sclareol produced in Saccha-
romyces cerevisiae; dammarenediol-II produced in Pichia 
pastoris; β-carotene produced in Escherichia coli and so 
on [6, 17, 21, 28, 35]. Limonene biosynthesis has been 
widely studied in other microorganisms including E. coli 
[1, 11, 33] and S. cerevisiae [4, 13]. In yeast, isopentenyl 
diphosphate (IPP) and its isomer dimethylallyl diphos-
phate (DMAPP), the two common building blocks, are 
the precursors of all terpenoids and they are derived 
from the mevalonic acid (MVA) pathway, and geranyl 
diphosphate (GPP) is the direct precursor of monoterpe-
nes catalyzed by geranyl/farnesyl diphosphate synthase 
(ERG20) [7] (Fig. 1). Limonene can be produced by intro-
ducing one key enzyme, limonene synthase (LS) into the 
pathway based on GPP [4, 13]. LS catalyzes the intramo-
lecular cyclization of GPP to gain limonene.
Yarrowia lipolytica as a non-conventional yeast is con-
sidered non-pathogenic and generally regarded as safe 
(GRAS). The availability of suitable metabolic engineer-
ing tools and the full genome sequence of Y. lipolytica 
make it a favorable host for producing pharmaceutical 
and food additives, and some studies have verified natu-
ral products produced in this strain [3, 21, 34]. Yarrowia 
lipolytica has the ability to grow to high biomass yield 
on simple substrates. A wide range of compounds can 
be produced by Y. lipolytica from glycerol, a side prod-
uct of biodiesel production [8, 21, 25]. In this study, we 
aim to construct a limonene biosynthesis pathway in Y. 
lipolytica and then metabolically engineer this strain for 
efficient production of limonene. To reach the target, two 
genes encoding neryl diphosphate synthase 1 (NDPS1) 
and limonene synthase (LS) were codon-optimized 
and  heterologously expressed in Y. lipolytica. Secondly, 
to enhance limonene production, several genes involved 
in the MVA pathway were overexpressed, either in differ-
ent copies of the same gene or in combination. Lastly, the 
optimized addition of pyruvic acid and dodecane further 
improved limonene production. By combining metabolic 
engineering and optimization of genes expression, an 
approximately 226-fold increase in limonene productivity 
was obtained in comparison with the initial strain.
Methods
Strains, vectors, chemicals, and culture media
The vectors and strains used in this study are listed in 
Tables  1 and 2, respectively. The auxotrophic Y. lipol-
ytica strain Po1f was used as the target gene expression 
host in this study. This Y. lipolytica strain and the plas-
mids pINA1269 and pINA1312 have been previously 
described by Madzak et al. [18]. Yarrowia lipolytica cells 
were cultured at 30 °C in YPD medium (1 % yeast extract, 
2 % peptone, and 2 % glucose) or YNB medium (0.67 % 
yeast nitrogen base without amino acids, 1 % glucose, and 
1.6  % agar). The rich medium YPD was used for strain 
activation and fermentation, while the synthetic medium 
YNB, lacking leucine and uracil where appropriate, was 
used for the screening of transformants. Escherichia coli 
strain JM109 or DH5α was used as a host for plasmid 
proliferation and construction of recombinant vectors. 
The cells were grown in Luria–Bertani (LB) complete 
Fig. 1 Biosynthesis pathway for limonene production in Y. lipolytica. IPP and DMAPP are converted to NPP by neryl diphosphate synthase 1 (NDPS1) 
and then NPP is further converted to limonene by limonene synthase (LS). Blue arrows represent that the pathways were exogenously integrated in 
Y. lipolytica, while red arrows represent that the pathways were overexpressed in Y. lipolytica. Single arrows represent the one‑step conversions, while 
triple arrows represent multiple steps
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medium (0.5 % yeast extract, 1 % tryptone, and 1 % NaCl) 
at 37  °C for 12  h. Suitable antibiotics or nutrients were 
added when necessary at the following final concentra-
tions: ampicillin, 100 mg/L; kanamycin 50 mg/L; leucine 
0.3 g/L. Plasmid extraction, gel extraction, and purifica-
tion of DNA were conducted using assay kits from San-
gon Biotech Co., Ltd. (Shanghai, China). Primer synthesis 
was conducted by GeneRay Biotech Co., Ltd. (Shanghai, 
China). Pyruvic acid and dodecane were purchased from 
TCI Development Co., Ltd. (Shanghai, China). 
Plasmids construction
The gene encoding d-limonene synthase (LS, GenBank 
ID: AY055214.1) from Agastache rugosa and gene encod-
ing neryl diphosphate synthase 1 (NDPS1, GenBank ID: 
NM_001247704.1) from Solanum lycopersicum were 
codon-optimized and synthesized by GeneRay Biotech. 
The transit peptides of both genes were removed accord-
ing to the literatures [5, 26]. The truncated genes were 
named tLS and tNDPS1, respectively. The tLS gene and 
tNDPS1 gene were cloned into p1312 with primers P1/
P2 and P3/P4 to obtain vectors p1312-tLS and p1312-
tNDPS1, respectively (Table  3). Then the expression 
cassette P-tLS-T was cloned into p1312-tNDPS1 with 
primers P5/P6 to obtain vector p1312LN. The genes 
HMG1, IDI1, ERG8, ERG10, ERG12, ERG19 amplified 
from the genome of Po1f with tLS and tNDPS1 were 
cloned into p1269 with primers P7/P8, P9/P10, P11/
P12, P13/P14, P15/P16, P17/P18, P1/P2, and P3/P4 to 
obtain the respective vectors p1269HMG1, p1269IDI1, 
p1269ERG8, p1269ERG10, p1269ERG12, p1269ERG19, 
p1269tLS, p1269tNPDS1. Afterwards, the expres-
sion cassettes P-tHMG1-T, P-HMG1-T, P-IDI1-T, 
P-ERG8-T, P-ERG10-T, P-ERG12-T, P-ERG19-T, P-tLS-
T, and P-tNDPS1-T were cloned into p1269tHMG1, 
p1269HMG1, p1269IDI1 with primers P19/P20 to 
obtain p1269tHMG1tHMG1, p1269HMG1HMG1, 
p1269IDI1IDI1, p1269HMG1tLS and p1269HMG1t-
NPDS1, p1269HMG1ERG8, p1269HMG1ERG10, 
p1269HMG1ERG12, p1269HMG1ERG19, p1269HM-
G1IDI1, respectively. Then the expression cas-
settes P-tHMG1-T and P-IDI1-T were cloned into 
Table 1 Vectors used in this study
Vectors Description Source
pINA1312 Y. lipolytica‑integrative plasmid, hp4d promoter, XPR2 terminator, ura3d1 selection marker, KmR [22]
pINA1269 Y. lipolytica‑integrative plasmid, hp4d promoter, XPR2 terminator, LEU2 selection marker, AmpR [22]
p1312‑tLS Constitutively expressed truncated LS gene This study
p1312‑tNDPS1 Constitutively expressed truncated NDPS1 gene This study
p1312wLN Constitutively expressed tLS and tNDPS1 genes This study 
p1312LN Constitutively expressed codon‑optimized tLS and codon‑optimized tNDPS1 genes This study
p1269tHMG1 Constitutively expressed tHMG1 gene This study
p1269HMG1 Constitutively expressed HMG1 gene This study
p1269IDI1 Constitutively expressed IDI1 gene This study
p1269ERG8 Constitutively expressed ERG8 gene This study
p1269ERG10 Constitutively expressed ERG10 gene This study
p1269ERG12 Constitutively expressed ERG12 gene This study
p1269ERG19 Constitutively expressed ERG19 gene This study
p1269tLS Constitutively expressed tLS gene This study
p1269tNPDS1 Constitutively expressed tNDPS1 gene This study
p1269tHMG1tHMG1 Constitutively expressed tHMG1 gene of two copies This study
p1269tHMG1tHMG1tHMG1 Constitutively expressed tHMG1 gene of three copies This study
p1269HMG1HMG1 Constitutively expressed HMG1 gene of two copies This study
p1269IDI1IDI1 Constitutively expressed IDI1 gene of two copies This study
p1269IDI1IDI1IDI1 Constitutively expressed IDI1 gene of three copies This study
p1269HMG1IDI1 Constitutively expressed HMG1 and IDI1 genes This study
p1269HMG1ERG8 Constitutively expressed HMG1 and ERG8 genes This study
p1269HMG1ERG10 Constitutively expressed HMG1 and ERG10 genes This study
p1269HMG1ERG12 Constitutively expressed HMG1 and ERG12 genes This study
p1269HMG1ERG19 Constitutively expressed HMG1 and ERG19 genes This study
p1269HMG1tLS Constitutively expressed HMG1 and tLS genes This study
p1269HMG1tNPDS1 Constitutively expressed HMG1 and tNDPS1 genes This study 
Page 4 of 11Cao et al. Biotechnol Biofuels  (2016) 9:214 
p1269tHMG1tHMG1 and p1269IDI1IDI1 with prim-
ers P21/P22 to obtain p1269tHMG1tHMG1tHMG1 
and p1269IDI1IDI1IDI1, respectively. All the plasmids 
were constructed using the One Step Cloning Kit from 
Vazyme Biotech Co., Ltd. (Nanjing, China).
Strain construction
p1312LN was linearized with NotI and then was 
transformed into competent Po1f cells using the kit, 
Frozen-EZ yeast transformation II. After transforma-
tion, cells were cultured on YNB medium plates with 
leucine added. The right colonies verified with prim-
ers P1/P2 and P3/P4 were named Po1f-LN-000. Then, 
p1269tHMG1, p1269tHMG1tHMG1, and p1269tH-
MG1tHMG1tHMG1 were linearized with ApaI 
while p1269HMG1, p1269HMG1HMG1, p1269IDI1, 
p1269IDI1IDI1, and p1269IDI1IDI1IDI1 were linearized 
with BsrGI. All these linearized plasmids were trans-
formed into competent Po1f-LN-000 cells, respectively. 
These cells were cultured on YNB medium plates and 
the right colonies, verified with primers P23/P24, P25/
P26, and P27/P28 were named Po1f-LN-001, Po1f-
LN-002, Po1f-LN-003, Po1f-LN-004, Po1f-LN-005, 
Po1f-LN-006, Po1f-LN-007, and Po1f-LN-008, respec-
tively. Afterwards, p1269HMG1tLS, p1269HMG1t-
NPDS1, p1269HMG1ERG8, p1269HMG1ERG10, 
p1269HMG1ERG12, p1269HMG1ERG19, and 
p1269HMG1IDI1 were linearized separately with BsrGI 
and transformed into Po1f-LN-000. After verification, 
the right colonies obtained were therefore named Po1f-
LN-011, Po1f-LN-021, Po1f-LN-031, Po1f-LN-041, Po1f-
LN-051, Po1f-LN-061, and Po1f-LN-071, respectively.
Yeast cultivation
YPD medium was used to cultivate the engineered 
strains. All strains were firstly inoculated into 10 mL cul-
ture tubes containing 2 mL medium, and grown at 30 °C 
at 220 rpm to reach an OD600 of about 1.0. The cultures 
were started by inoculating 50  mL medium contain-
ing 1 mL dodecane as organic extractant phase with the 
preculture [30] and the initial OD600 was 0.01. Strains 
were cultured at 30  °C and 220  rpm for 3  days. All the 
flask fermentation results represented the mean  ±  S.D. 
of three independent experiments. At the same time, to 
investigate the influence of the addition of pyruvic acid 
in vitro, pyruvic acid of different concentrations 2, 4, and 
8 g/L were added to the medium of strain Po1f-LN-051, 
respectively. Furthermore, effects of the amount of dode-
cane on limonene synthesis by strain Po1f-LN-051 were 
also surveyed, with dodecane varying from 2 to 10  % 
(volume/volume) and constant pyruvic acid concentra-
tion of 4 g/L.
Analysis
Optical densities at 600 nm (OD600) were measured using 
a Shimadzu UV-1800 spectrophotometer (Shimadzu Co., 
Table 2 Strains used in this study
Strains Description Source
Escherichia coli
DH5α, JM109 For construction of recombinant vectors Invitrogen
Yarrowia lipolytica
Po1f leu2−, ura3− [2]
Po1f‑LN‑000 Po1f cells harboring p1312LN This study
Po1f‑LN‑001 Po1f cells harboring p1312LN and p1269tHMG1 This study
Po1f‑LN‑002 Po1f cells harboring p1312LN and p1269tHMG1tHMG1 This study
Po1f‑LN‑003 Po1f cells harboring p1312LN and p1269tHMG1tHMG1tHMG1 This study
Po1f‑LN‑004 Po1f cells harboring p1312LN and p1269HMG1 This study
Po1f‑LN‑005 Po1f cells harboring p1312LN and p1269HMG1HMG1 This study
Po1f‑LN‑006 Po1f cells harboring p1312LN and p1269IDI1 This study
Po1f‑LN‑007 Po1f cells harboring p1312LN and p1269IDI1IDI1 This study
Po1f‑LN‑008 Po1f cells harboring p1312LN and p1269IDI1IDI1IDI1 This study
Po1f‑LN‑011 Po1f cells harboring p1312LN and p1269HMG1tLS This study
Po1f‑LN‑021 Po1f cells harboring p1312LN and p1269HMG1tNDPS1 This study
Po1f‑LN‑031 Po1f cells harboring p1312LN and p1269HMG1ERG8 This study
Po1f‑LN‑041 Po1f cells harboring p1312LN and p1269HMG1ERG10 This study
Po1f‑LN‑051 Po1f cells harboring p1312LN and p1269HMG1ERG12 This study
Po1f‑LN‑061 Po1f cells harboring p1312LN and p1269HMG1ERG19 This study
Po1f‑LN‑071 Po1f cells harboring p1312LN and p1269HMG1IDI1 This study
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Kyoto, Japan). 5  mL of wet cell culture was harvested, 
washed twice with distilled water, and centrifuged at 
12,000 rpm for 5 min. The upper layer was discarded and 
dry cell weight was determined by measuring the weight 
of cell pellets which were dried at 105 °C for 48 h.
For limonene detection, the dodecane layers were 
collected and myrcene was used as an internal stand-
ard. The dodecane overlay samples were mixed with 
myrcene by 4:1 (v/v). Then the mixture (1 μL) was ana-
lyzed by GC/MS using an Agilent System 6890 gas 
chromatograph coupled to an Agilent 5975 quadrupole 
mass selective detector (EI) (Agilent Technologies, Santa 
Clara, CA), equipped with a HP-5 (30  m  ×  0.25  mm, 
0.25 µm film thickness) GC column. The GC oven tem-
perature program was as follows: 100  °C for 1  min, a 
ramp of 0.5 °C/min to 102 °C, and then a rise to 280 °C in 
5 min. The split ratio was 20:1. Limonene and myrcene 
standards (purchased from Sigma-Aldrich) were used 
for quantification.
For squalene extraction, 1.8 mL of fermentation broth 
was collected and resuspended with 600  μL of 20  % 
KOH/50 % ethanol solution then voltexed at once using 
a multi holder for 5  min at the fastest rate. After that, 
the tubes were placed into boiling water for 5 min then 
cooled in ice water. HPLC grade hexane 600  μL was 
added to the tubes, which was then voltexed using a multi 
holder for 5 min. The two phases were separated by cen-
trifugation at 12,000 rpm for 5 min at 4 °C. After centrif-
ugation, 400 μL of top hexane layer was transferred into 
the new 1.5  mL eppendorf (EP) tubes and evaporated 
using a vacuum dryer for 15 min at a low dry rate, after 
that 50 μL of HPLC grade ethanol and 450 μL of HPLC 
grade acetonitrile were added to the tubes. Squalene was 
quantified with the Shimadzu LC-20A (Shimadzu Co., 
Kyoto, Japan) equipped with C18 column (Phenomenex 
Kinetex 5  μm C18) and a UV detector. The wavelength 
was 195  nm and mobile phase was 100  % acetonitrile 
with 2  mL/min flow rate and a column temperature of 
Table 3 Primers used in this study
Restriction sites are underlined
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35 °C. Squalene standard (purchased from TCI Biotech) 
was used for quantification.
Inhibitory effects of d‑limonene on Y. lipolytica Po1f
A fixed volume of serially diluted d-limonene in etha-
nol ranging from 100 to 3000  mg/L was added to YPD 
medium with 0.5  % Tween 80  v/v. Tween 80 was dis-
solved into the medium to increase the solubility of 
d-limonene. YPD medium contained 0.5 % Tween 80v/v 
and ethanol was regarded as control.
Results and discussion
Construction of the limonene synthetic pathway in Y. 
lipolytica
Though Y. lipolytica possesses a native MVA path-
way which can supply the intermediates DMAPP and 
IPP (Fig.  1), it cannot produce limonene because of the 
absence of limonene synthase. Consequently, the gene 
encoding d-limonene synthase (LS) was first amplified 
from the cDNAs of Agastache rugosa. Meanwhile, to 
overcome the possible expression problem a codon-opti-
mized artificial LS gene was also designed and amplified. 
The integrative vector pINA1312 carrying either the wild-
type LS gene or the codon-optimized artificial LS gene 
was successfully integrated into the chromosome of Po1f 
strain, respectively. Unfortunately, after three-day cultiva-
tion of these two engineered strains, no limonene could 
be detected in the dodecane layers by GC–MS (data not 
shown), based on the relative retention time and total ion 
mass spectral comparison with the external standard.
Geranyl diphosphate (GPP) has been generally 
regarded as the substrate for monoterpenes, while 
very little was reported about NPP, the isomer of GPP. 
Recently, monoterpenes in the glandular trichomes of 
tomato were found to be synthesized from NPP precur-
sor rather than GPP [26]. Another study showed that 
NPP instead of GPP was the substrate of limonene in S. 
cerevisiae [16]. Therefore, we hypothesized that NPP 
might also be the major substrate for limonene biosyn-
thesis in Y. lipolytica. To address the precursor problem, 
codon-optimized NDPS1 gene, which encodes NDPS1 
catalyzing the conversion of DMAPP and IPP to NPP in 
Solanum lycopersicum, were integrated into the chromo-
some of Y. lipolytica Po1f together with the codon-opti-
mized LS gene to obtain strain Po1f-LN-000. Dodecane 
layers were collected on the third day and tested by GC/
MS. Limonene (m/z 68.1, 93.1, and 136.5) was monitored 
at 3.9  min (Fig.  2). The engineered strain Po1f-LN-000 
produced limonene in detectable quantities at 0.006 mg/g 
DCW and was therefore used as the initial limonene-
producing strain in this study (Fig. 3). Thus, using codon-
optimized gene tLS from Agastache rugosa and tNDPS1 
from S. lycopersicum, the biosynthetic pathway for 
limonene production was successfully constructed in Y. 
lipolytica. The results also demonstrated that introduc-
tion of NPP pathway is essential for limonene production 
and the genes derived from plants were necessary to be 
codon-optimized when expressed in Y. lipolytica. After 
this initial success in metabolic engineering of Y. lipol-
ytica for limonene production, further stepwise improve-
ments were attempted using this Po1f-LN-000 strain. The 
optimized nucleotide sequences of truncated LS gene and 
truncated NDPS1 gene were provided in Additional file 1.
Improving limonene production by overexpressing 
HMG‑CoA reductase gene
The enzyme 3-hydroxy-3-methylglutaryl-coenzyme A 
(HMG-CoA) reductase is well known as the major rate-
limiting enzyme of the mevalonate (MVA) pathway in 
many organisms, including yeasts. Overexpression of 
the catalytic domain of the HMGR (producing a form 
of the enzyme that lacks the membrane-binding region, 
namely truncated HMG-CoA reductase gene or tHMG1) 
in yeasts has been shown to boost production of isopre-
noid biosynthesis [9, 24, 29]. Furthermore, in the ole-
aginous yeast Y. lipolytica, it was also reported that the 
integration of HMG1 into the engineered strain led to a 
6.9-fold increase in lycopene content after 96 h of culti-
vation, probably attributable to the increased supply of 
precursors [21]. Thus, it was determined whether over-
expression of HMG1 could increase limonene produc-
tion in limonene-producing Y. lipolytica cells. For this 
purpose, heterologous tHMG1 gene from S. cerevisiae 
and homologous HMG1 gene from Y. lipolytica were 
overexpressed under the control of hy4d promoter in the 
limonene-producing strain Po1f-LN-000, as showed in 
Fig. 3, resulting in the recombinant strains Po1f-LN-001 
and Po1f-LN-004, respectively. Limonene production 
was only improved around 30  % in the heterologous 
recombinant strain Po1f-LN-001, while homologous 
recombination of HMG1 significantly enhanced the 
limonene-producing level. In the fermentation broths of 
the strain Po1f-LN-004, the limonene titer (or content) 
increased from 0.006  mg/g DCW to 0.11  ±  0.01  mg/g 
DCW, 18-fold higher than the control strain Po1f-
LN-000 (Fig. 3). These results did confirm that the pro-
duction of limonene was accumulated by the duplication 
of HMG-CoA reductase gene and, more importantly, the 
overexpression of homologous HMG1 was more effective 
to increase the biosynthesis of limonene in Y. lipolytica.
Further enhancing the HMG1 copy number might lead 
to further improvement of the limonene production. 
To validate the hypothesis, the plasmids carrying extra 
gene copies were introduced into Po1f-LN-000, yield-
ing another type of recombinant strains (Po1f-LN-005) 
that contain HMG1 of two copies. We found that the two 
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copies of HMG1 did not necessarily improve limonene 
production, instead a slight decrease in limonene titer 
was observed. Similar phenomenon also happened for 
strains Po1f-LN-002 harboring two copies of tHMG1 and 
Po1f-LN-003 with three copies of tHMG1 (Fig. 3). These 
results implied that it was not necessary to increase 
the copy number of HMG-CoA reductase gene, and 
single copy of homologous HMG1 was good enough for 
limonene overproduction in Y. lipolytica.
Effects of re‑engineering of limonene synthesis 
on limonene production
Since there was only a single copy of tLS and tNDPS1 
gene in chromosome with relatively low expression 
strength, limonene synthase and neryl diphosphate syn-
thase enzymes might be rate limiting for limonene pro-
duction. In order to investigate the effects of increased 
activities of these enzymes on limonene production, 
plasmids p1269HMG1tLS and p1269HMG1tNDPS were 
transformed into strain Po1f-LN-000 (Po1f cells harbor-
ing p1312LN and p1269HMG1) to generate strain Po1f-
LN-011 with two copies of tLS and strain Po1f-LN-021 
with two copies of tNDPS1, respectively. Shake flask cul-
tures of strain Po1f-LN-004 and the engineered strains 
of Po1f-LN-011and Po1f-LN-021 were carried out and 
the limonene productions were compared (Fig.  3). In 
contrast to the slight decrease in limonene production 
in strain Po1f-LN-021, the final limonene concentration 
by Po1f-LN-011 doubled in comparison with that of the 
engineered strain Po1f-LN-004, suggesting that strength-
ening the conversion of precursor NPP to limonene plays 
a more important role in improving the production. In 
contrast to the effectiveness of enhancing tLS expression, 
strain with extra copy of tNDPS1 produced less amount 
of limonene than that of Po1f-LN-004 strain, indicating 
Fig. 2 GC–MS analysis of limonene from the dodecane phase of 
the cultures in engineered Y. lipolytica. The strain was cultivated in 
YPD medium for 72 h. a Limonene standard; b Mass spectrum of 
limonene standard; c Limonene obtained in YPD medium contain‑
ing 4 g/L pyruvic acid of Po1f‑LN‑051; d Mass spectrum of limonene 
obtained in YPD medium containing 4 g/L pyruvic acid of Po1f‑
LN‑051
tLS - + + + + + + + + + ++ + + + + + + 
tNDPS1 - + + + + + + + + + + ++ + + + + + 
tHMG1 - - + ++ +++ - - - - - - - - - - - - 
HMG1 - - - - - + ++ - - - + + + + + + + 
IDI1 - - - - - - - + ++ +++ - - - - - - + 
ERG8 - - - - - - - - - - - - + - - - - 
ERG10 - - - - - - - - - - - - - + - - - 
ERG12 - - - - - - - - - - - - - - + - - 
ERG19 - - - - - - - - - - - - - - - + - 
Fig. 3 Quantitative analysis of limonene production in engineered 
Y. lipolytica. Limonene productions in the engineered strains 
Po1f‑LN‑000, Po1f‑LN‑001, Po1f‑LN‑002, Po1f‑LN‑003, Po1f‑LN‑004, 
Po1f‑LN‑005, Po1f‑LN‑006, Po1f‑LN‑007, Po1f‑LN‑008, Po1f‑LN‑011, 
Po1f‑LN‑021, Po1f‑LN‑031, Po1f‑LN‑041, Po1f‑LN‑051, Po1f‑LN‑061, 
Po1f‑LN‑071. All strains were cultured in YPD medium for 3 days. 
Three repeats were performed for each strain, and error bars represent 
standard deviations
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that single expression of tNDPS1 was more efficient in 
converting IPP and DMAPP into NPP.
Effects of overexpression of gene encoding isopentenyl 
diphosphate isomerase on limonene production
The gene IDI1 (Fig. 1) encodes for an isopentenyl diphos-
phate isomerase that catalyzes an essential step in the 
sterol pathway, the isomerization of IPP to DMAPP. 
A number of works focused on the overexpression of 
IDI gene to improve isoprenoid accumulation in E. coli 
[14, 20, 31]. In S. cerevisiae, an extra copy of IDI1 was 
introduced into the genome leading to a 50  % increase 
in geraniol yield. Furthermore, overexpression of IDI1 
using a multi-copy plasmid in the engineered strains 
increased geraniol yield 1.45-fold [15]. In another study, 
overexpression of IDI1 increased the monoterpene cin-
eole production by twofold, and approximately fivefold 
increase was obtained when IDI1 was expressed from a 
high copy plasmid in the engineered S. cerevisiae strains 
[12]. In order to investigate the effects of overexpressing 
homologous IDI on limonene production, the plasmids 
carrying different copies of IDI were transformed into 
Po1f-LN-000 strain resulting in strains Po1f-LN-006 (sin-
gle copy), Po1f-LN-007 (two copies), and Po1f-LN-008 
(three copies), respectively. The data showed that sin-
gle copy of IDI1 gene could only increase the limonene 
concentration by 30  %. However, there was no obvious 
difference in limonene production with the increase 
in copy number of the IDI1 gene. Although one extract 
IDI1 integration could enhance the limonene biosynthe-
sis in Y. lipolytica, the improvement was limited com-
pared with the overexpression of HMG1 (Fig.  3). When 
both HMG1 and IDI1 genes were overexpressed in Po1f-
LN-000 (resulting in strain Po1f-LN-071), interestingly, 
we observed a slight decrease in limonene production 
instead of the production enhancement in comparison 
with Po1f-LN-004, suggesting that IDI1 might exert lim-
ited influence on limonene accumulation in Y. lipolytica.
Optimization of mevalonate pathway improved limonene 
production
Our previous work has already shown that the homolo-
gous overexpression of HMG1 was efficient in boost-
ing limonene production in Y. lipolytica. In addition 
to the overexpression of the HMG1 gene alone, we also 
emphasized on the co-overexpression of the HMG1 gene 
together with other genes involved in the MVA path-
way (e.g., ERG8 encoding phosphomevalonate kinase, 
ERG10 encoding acetoacetyl-CoA thiolase, ERG12 
encoding mevalonate kinase, and ERG19 encoding meva-
lonate diphosphate decarboxylase), in order to further 
explore potential and efficient strategies for improving 
limonene productivity. The plasmids p1269HMG1ERG8, 
p1269HMG1ERG10, p1269HMG1ERG12, and 
p1269HMG1ERG19 were integrated into Po1f-LN-000 
separately, resulting strains Po1f-LN-031, Po1f-LN-041, 
Po1f-LN-051, and Po1f-LN-061, respectively. As shown 
in Fig. 3, among all of the above recombinant strains, the 
improved limonene production could only be observed 
for the strain Po1f-LN-051 in which ERG12 and HMG1 
were co-overexpressed. One hundred and 12- and 6-fold 
increases in limonene content were obtained in Po1f-
LN-051 in comparison with those obtained by the control 
strains of Po1f-LN-000 and Po1f-LN-004, respectively. 
The results suggested the significant importance of meva-
lonate biosynthesis and its subsequent phosphorylation 
in supplying an enhanced carbon flux for the improved 
production of MVA pathway-related metabolites. It has 
not yet been reported that the overexpression of the 
ERG12 gene is favorable to the synthesis of monoterpene. 
Actually, when both the HMG1 and ERG12 genes were 
overexpressed, we also observed a 2.5-fold increase in the 
content of squalene, a shunt biosynthetic product (i.e., 
0.36  mg/g DCW and 0.96  mg/g DCW in strains Po1f-
LN-000 and Po1f-LN-051, respectively), while the growth 
rates of these strains did not vary too much (Fig. 4).
Effects of pyruvic acid and dodecane addition
Based on the successes in genetic modification of Y. 
lipolytica for improving limonene biosynthesis, exten-
sive efforts have been made in the optimization of cul-
ture medium to further increase limonene productivity. 
Among several key influential factors, effects of pyruvic 
acid and dodecane were investigated in this study. Pyru-
vic acid is a substrate of the DXP pathway and previous 
studies indicated that the addition of pyruvic acid as an 
auxiliary carbon source could increase amorphadiene 
and limonene accumulation in E. coli [10, 36]. In order 
to evaluate the effect of the amount of pyruvic acid on 
the growth of Y. lipolytica and limonene production, 
shake flask cultures with initial pyruvic acid concentra-
tions varying from 0 to 8 g/L in YPD medium were con-
ducted and compared. Although no obvious differences 
were observed for cell growth, the limonene contents 
were increased and 4 g/L of initial pyruvic acid seemed 
to favor the limonene production best (Fig. 5b). We also 
tested the use of glycerol as a sole carbon source or aux-
iliary carbon source. However, limonene productions 
were decreased apparently only as a sole carbon source in 
comparison with other combinations (Fig.  5a). The rea-
son may be that the promoter when glycerol was used as 
substrate resulted in the lower expression of genes and 
reduced the production of limonene.
Limonene is produced and secreted by Y. lipolytica into 
the medium. Usually dodecane is added into the culture 
medium to enrich limonene. To investigate the amount 
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of dodecane on limonene production, the cultures were 
performed with different initial dodecane concentrations 
varying from 2 to 10 % in YPD medium with 4 g/L pyru-
vic acid as the auxiliary carbon source. Maximum pro-
duction of limonene in recombinant cells was observed 
when dodecane concentration was 8 %, and no significant 
differences on cell growth were found in all cases. With 
the optimized pyruvic acid and dodecane concentrations, 
a limonene production of 23.56  mg/L and 1.36  mg/g 
DCW was achieved, approximately 226-fold higher 
than those of the control strain Po1f-LN-000 (with only 
codon-optimized LS and NDPS1 genes overexpressed) 
(Fig. 5c). These results demonstrated that both the addi-
tion of pyruvic acid and the appropriate dodecane con-
centration were important in enhancing limonene 
production by Y. lipolytica.
Inhibitory effects of d‑limonene on Y. lipolytica
As seen from the Fig.  6, yeast growth was similar to 
the control when the concentration of limonene in the 
Fig. 4 a The OD600 values of strains Po1f, Po1f‑LN‑000, Po1f‑LN‑004, and Po1f‑LN‑051 cultured in YPD medium, measured at 0, 8, 14, 24, 32, 48, 72, 
and 96 h. b Squalene production in strains Po1f, Po1f‑LN‑000, Po1f‑LN‑004, Po1f‑LN‑051 cultured in YPD medium for 5 days
Fig. 5 Effects of different combinations of glucose and glycerol as substrate and heterologous addition of pyruvic acid and dodecane on the pro‑
duction of limonene. a Glucose of 2, 1.5, 1, 0.5, 0 % were respectively combined with glycerol of 0, 0.5, 1, 1.5, 2 % as substrate in the YP medium of 
strain Po1f‑LN‑051. b Pyruvic acid was added to the YPD medium of strain Po1f‑LN‑051 to a final concentration of 0, 2 , 4, or 8 g/L. c Dodecane was 
added to the YPD medium of strain Po1f‑LN‑051 with 4 g/L pyruvic acid as the auxiliary carbon source and the proportion of dodecane was from 2 
to 10 %. Three repeats were performed for each medium, and error bars represent standard deviations. t tests were conducted to evaluate statistical 
significance at p < 0.05. Particularly, for (a) the asterisk shows statistical significance between 2 % glucose and other combinations of glucose and 
glycerol, for (b) the asterisk shows statistical significance between YPD medium containing 0 g/L pyruvic acid and other concentrations of pyruvic 
acid, and for (c) the asterisk shows statistical significance between YPD medium containing 2 % dodecane and other proportions of dodecane
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medium was lower than 500 mg/L. The cell growth was 
significantly inhibited when limonene concentration was 
higher than 500 mg/L.
Limonene biosynthesis has been widely studied in 
E. coli and S. cerevisiae. In E. coli, the highest limonene 
production was 435  mg/L from simple sugars using a 
heterologous mevalonate pathway. Furthermore, the puri-
fication of limonene produced in E. coli was also explored 
recently [1, 4, 13, 33]. In S. cerevisiae, limonene trapped in 
a dodecane phase resulted in the recovery of 0.028 mg/L 
(+)-limonene and 0.060  mg/L (−)-limonene in strains 
expressing a mutant ERG20 enzyme and the truncated 
Citrus and Perilla synthases, respectively. Another study 
showed that the best limonene titer obtained in S. cer-
evisiae was 1.48  ±  0.22  mg/L when a truncated HMG1 
and upc2-1 were expressed with codon-optimized citrus 
(+)-limonene synthase in supplemented YP medium. 
Although the yield of limonene obtained in our study is 
lower than that in E. coli, considering the non-GRAS sta-
tus of E. coli, it is of great commercial interest for GRAS 
status organism Y. lipolytica to produce limonene. In addi-
tion, the limonene production of the engineered strain in 
this study is the highest reported to date in yeasts, which 
might prompt further research on the biosynthesis of var-
ious terpenoids in Y. lipolytica.
Conclusion
Limonene, an important monoterpene, is used as a pre-
cursor of many flavoring, pharmaceutical, and biodiesel 
products and majorly supplied limitedly in plant source. 
Recently, microbial production of valuable chemicals 
by economically efficient bioprocesses has emerged as 
an attractive alternative way. Here, our work presented 
the first report of the limonene biosynthetic pathway in 
oleaginous yeast Y. lipolytica by heterologous expres-
sion of codon-optimized tLS and tNDPS1 genes. Specifi-
cally, we optimized the MVA pathway and re-engineered 
the limonene biosynthetic pathway for further stepwise 
improvement of limonene production capacity. Combin-
ing this metabolic engineering strategy with the optimi-
zation of medium in flask culture, a maximum limonene 
titer and content of 23.56 mg/L and 1.36 mg/g DCW (the 
highest reported in yeasts) was achieved in this study, 
showing approximately 226-fold increase compared with 
the initial yield of 0.006  mg/g DCW. As a conclusion, 
we demonstrated that Y. lipolytica could be a compel-
ling platform for a feasible, scalable, and economic route 
to the overproduction of limonene derivatives, and even 
other monoterpenes. In our next experiments, fermenta-
tion strategies will be developed based on the engineered 
strains to obtain enhanced production. We will be focus-
ing on several issues, such as optimizing the medium 
compositions and fermentation parameters, selecting 
suitable solvent and antifoam.
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